67 related articles for article (PubMed ID: 4181519)
1. Effect of TSH on the 24-hr 131-I uptake in Graves' disease.
Charkes ND
J Nucl Med; 1969 May; 10(5):246-8. PubMed ID: 4181519
[No Abstract] [Full Text] [Related]
2. In vitro demonstration of normal thyrotropin (TSH) responsiveness in thyroid tissue from patients with Graves' disease.
Field JB; Larsen PR; Yamashita K
Trans Assoc Am Physicians; 1973; 86():300-9. PubMed ID: 4363386
[No Abstract] [Full Text] [Related]
3. [Inorganic and organic phases of radioiodine metabolism in the thyroid in Basedow patients treated with synthetic thyroid antagonists].
Valentini F; Lodeserto A; Reschini E; Vivarelli S; Miedico D
Folia Endocrinol; 1968 Aug; 21(4):385-95. PubMed ID: 4186148
[No Abstract] [Full Text] [Related]
4. Thyroid responsiveness in Gravesian ophthalmopathy.
Mendelsohn LV; Mouton DE; Goldzieher JW
Arch Intern Med; 1972 Jul; 130(1):119-20. PubMed ID: 5067864
[No Abstract] [Full Text] [Related]
5. Effect of thyrotropin and adenosine on inositol phospholipids pathway in human thyroid in Graves' disease.
Zarzycki W; Mośko P; Jaroszewicz L; Kinalska I
Biochem Biophys Res Commun; 1994 Nov; 205(1):584-9. PubMed ID: 7999083
[TBL] [Abstract][Full Text] [Related]
6. Effect of TSH on iodine metabolism and intermediary metabolism in tissue from patients with Graves' disease.
Field JB; Larsen PR; Yamashita K; Chayoth R
J Clin Endocrinol Metab; 1974 Nov; 39(5):942-9. PubMed ID: 4370784
[No Abstract] [Full Text] [Related]
7. [The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase].
Valentini F; Reschini E; Lodeserto A; Vivarelli S; Miedico D
Folia Endocrinol; 1968 Aug; 21(4):396-403. PubMed ID: 4185869
[No Abstract] [Full Text] [Related]
8. [Function of the euthyroid budgerigar thyroid gland after application of iodine and TSH].
Robiller F
Arch Exp Veterinarmed; 1974; 28(1):11-4. PubMed ID: 4848804
[No Abstract] [Full Text] [Related]
9. Observations on thyroid gland function in dogs: response to thyrotropin and thyroidectomy and determination of thyroxine secretion rate.
Kallfelz FA
Am J Vet Res; 1973 Apr; 34(4):535-8. PubMed ID: 4693811
[No Abstract] [Full Text] [Related]
10. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter.
Prendergast JJ; Miller JM
Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196
[No Abstract] [Full Text] [Related]
11. The TSH test in persons having received iodine compounds.
Papadopoulos SN; Livadas D; Sfontouris J; MacFarlane S; Koutras DA
Nucl Med (Stuttg); 1968; 7(1):65-72. PubMed ID: 5688418
[No Abstract] [Full Text] [Related]
12. TSH stimulation of 32P incorporation into phospholipids of thyroids from patients with Graves' disease.
Schneider PB
J Clin Endocrinol Metab; 1974 Jan; 38(1):148-50. PubMed ID: 4358643
[No Abstract] [Full Text] [Related]
13. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
Tamai H; Nakagawa T; Takahashi H; Ohsako N; Fukino O; Shinzato R; Suematsu H; Matsuzuka F; Kuma K; Nagataki S
J Nucl Med; 1980 Mar; 21(3):240-5. PubMed ID: 6892713
[No Abstract] [Full Text] [Related]
14. [Toxic adenoma. Study of 35 cases].
Barceló Lucerga B; Alcañiz Ferrando J; Ortiz Berrocal J; Salto Hernández L
Rev Iber Endocrinol; 1971; 18(106):369-83. PubMed ID: 5171341
[No Abstract] [Full Text] [Related]
15. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
16. [Effects of iodine-containing food on 99mTc and 131I uptake in patients with Graves' disease].
He GR; Ouyang W; Liu JH; Liu WY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1292-4. PubMed ID: 15567783
[TBL] [Abstract][Full Text] [Related]
17. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
[TBL] [Abstract][Full Text] [Related]
18. Expression of thioredoxin in patients with Graves' disease.
Kihara M; Kontani K; Yamauchi A; Miyauchi A; Nakamura H; Yodoi J; Yokomise H
Int J Mol Med; 2005 May; 15(5):795-9. PubMed ID: 15806300
[TBL] [Abstract][Full Text] [Related]
19. TSH-receptor antibody (TSH-R Ab) variations in patients undergoing subtotal thyroidectomy for Graves' disease: a prospective study.
Rubello D; Casara D; Pelizzo MR; Girelli ME; Piotto A; Piccolo M; Busnardo B
J Nucl Biol Med (1991); 1993 Jun; 37(2):73-6. PubMed ID: 8373836
[TBL] [Abstract][Full Text] [Related]
20. Metabolic clearance rates of diiodotyrosine in man.
Singer PA; Nicoloff JT
J Clin Endocrinol Metab; 1972 Apr; 34(4):666-70. PubMed ID: 4111067
[No Abstract] [Full Text] [Related]
[Next] [New Search]
